First Time Loading...

Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 39.5 USD -0.25%
Updated: May 16, 2024

Balance Sheet

Balance Sheet Decomposition
Rhythm Pharmaceuticals Inc

Current Assets 235.8m
Cash & Short-Term Investments 201.2m
Receivables 14.7m
Other Current Assets 19.9m
Non-Current Assets 22.9m
PP&E 1.8m
Intangibles 6.8m
Other Non-Current Assets 14.3m
Current Liabilities 54.2m
Accounts Payable 7.6m
Accrued Liabilities 35.2m
Other Current Liabilities 11.4m
Non-Current Liabilities 142.9m
Long-Term Debt 107.4m
Other Non-Current Liabilities 35.5m

Balance Sheet
Rhythm Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
0
35
7
34
50
62
101
59
128
60
Cash Equivalents
0
35
7
34
50
62
101
59
128
60
Short-Term Investments
0
0
4
114
203
230
72
236
206
216
Total Receivables
0
0
0
0
0
0
0
1
6
15
Accounts Receivables
0
0
0
0
0
0
0
1
6
15
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
3
9
Other Current Assets
0
1
1
3
7
10
9
13
12
9
Total Current Assets
0
36
11
151
259
302
182
308
354
308
PP&E Net
0
0
1
1
1
6
5
4
3
2
PP&E Gross
0
0
1
1
1
6
5
4
3
2
Accumulated Depreciation
0
0
0
0
1
1
1
2
3
4
Intangible Assets
0
0
0
0
0
0
0
5
8
7
Note Receivable
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
2
0
0
0
0
0
12
17
15
Total Assets
0
N/A
37
+18 550%
12
-67%
152
+1 133%
260
+72%
309
+19%
187
-39%
330
+76%
383
+16%
333
-13%
Liabilities
Accounts Payable
1
1
2
2
8
10
5
6
5
5
Accrued Liabilities
0
3
3
4
6
14
13
31
34
40
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
1
0
0
0
0
0
7
1
11
Total Current Liabilities
1
5
5
7
14
24
18
43
40
55
Long-Term Debt
0
0
0
0
0
0
0
0
76
106
Other Liabilities
0
0
0
0
0
3
3
2
3
2
Total Liabilities
1
N/A
5
+783%
5
-6%
7
+38%
14
+103%
28
+96%
21
-25%
45
+121%
118
+160%
163
+38%
Equity
Common Stock
0
40
40
0
0
0
0
0
0
0
Retained Earnings
40
51
77
110
185
325
459
529
710
895
Additional Paid In Capital
39
43
44
255
431
606
626
813
974
1 064
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
0
N/A
32
N/A
7
-77%
145
+1 884%
246
+70%
281
+14%
167
-41%
284
+71%
264
-7%
170
-36%
Total Liabilities & Equity
0
N/A
37
+18 550%
12
-67%
152
+1 133%
260
+72%
309
+19%
187
-39%
330
+76%
383
+16%
333
-13%
Shares Outstanding
Common Shares Outstanding
26
26
26
27
34
44
44
50
57
59

See Also

Discover More